Tau Protein “PET” Detection Study

The purpose of this study is to investigate the effectiveness and safety of a new injection—given in conjunction with a PET scan—to help detect tau protein in the brain. Tau protein is a key feature of Alzheimer’s disease that affects the nervous system and may occur well before clinical signs of the disease. Early detection could help with the diagnostic process, as well as the treatment of, Alzheimer’s disease.



  • Winter Park


Tau Protein “PET” Detection Study

Study Details

Is this study right for me?

This study may be a good fit if you or a loved one:

  • 50+ years of age.
  • A projected life expectancy of less than or equal to 1 year

More questions?

The Charter team is here to support you through this journey.

Please contact us via email or phone with any further questions you may have.

Sign Up

Register for a Prescreen

Thank you for your willingness to help advance new medicines. A prescreen is the first step to see if you qualify.

Simply fill out this form and one of our friendly team members will be happy to get in touch with you.

Prescreen Sign-Up

One of our team members will contact you to schedule a time that works best with your schedule.

Your contact information

Do you live in Central Florida?

Preferred Charter Research location

I would like to receive the Charter Research newsletter.

Comments (not required)

This field is for validation purposes and should be left unchanged.